Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies. (June 2013)
- Record Type:
- Journal Article
- Title:
- Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies. (June 2013)
- Main Title:
- Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies
- Authors:
- Perković, Ivana
Tršinar, Sara
Žanetić, Jelena
Kralj, Marijeta
Martin-Kleiner, Irena
Balzarini, Jan
Hadjipavlou-Litina, Dimitra
Katsori, Anna Maria
Zorc, Branka - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>A series of novel 1, 4-substituted semicarbazides <bold>5a–g</bold> with a primaquine moiety bridged by a carbonyl group at position 1 and a cycloalkyl, aryl, benzyloxy or hydroxy substituent at position <bold>4</bold> were prepared and biologically evaluated. The synthetic pathways applied for preparation of the title compounds involved benzotriazole as synthetic auxiliary. Primaquine semicarbazides <bold>5a–g</bold> and their synthetic precursors benzotriazolecarbonyl semicarbazides <bold>4</bold> were evaluated for cytostatic, antiviral and antioxidative activities. All compounds of the series <bold>5</bold> showed high selectivity towards MCF-7 cells (breast carcinoma) with IC<sub>50</sub> values in the low micromolar range and the most active was benzyl derivative <bold>5c</bold> (IC<sub>50</sub> 1 ± 0.2 <italic>µ</italic>M). The benzhydryl derivative <bold>5e</bold> showed significant cytostatic activities towards all the tested cell lines (IC<sub>50</sub> 4–18 <italic>µ</italic>M). The same compound was the strongest lipoxygenase inhibitor as well (51%). The highest antioxidant activity was demonstrated for the hydroxy derivative <bold>5g</bold> and benzotriazolecarbonyl semicarbazides <bold>4b, c</bold> (61.2–68.5%). No antiviral activity was observed against a wide variety of DNA and RNA viruses.</p> </abstract>
- Is Part Of:
- Journal of enzyme inhibition and medicinal chemistry. Volume 28:Number 3(2013:Jun.)
- Journal:
- Journal of enzyme inhibition and medicinal chemistry
- Issue:
- Volume 28:Number 3(2013:Jun.)
- Issue Display:
- Volume 28, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 28
- Issue:
- 3
- Issue Sort Value:
- 2013-0028-0003-0000
- Page Start:
- 601
- Page End:
- 610
- Publication Date:
- 2013-06
- Subjects:
- Enzyme inhibitors -- Periodicals
Enzyme Inhibitors -- periodicals
Biochemistry -- periodicals
572.7 - Journal URLs:
- http://informahealthcare.com/loi/enz ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/14756366.2012.663366 ↗
- Languages:
- English
- ISSNs:
- 1475-6366
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4979.465000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3775.xml